The early region 3 (E3) of group C human adenoviruses (Ads) contains nine open reading frames, seven of which have been shown to be expressed in infected cells. From map units 76 to 86 of Ad type 2 (Ad2), these include the 12.5-kilodalton protein (12.5K protein) (27) , 6 .7K (74) , gpl9K (49), 11 .6K (67) , 10 .4K (66) , 14 .5K (65) , and 14.7K (69) . The E3 region is dispensable for growth of the virus in tissue culture but conserved among most Ad serotypes (12, 29, 61) and appears to play a role in the modulation of the host immune response to infection (21, 26, 75) . The best characterized of the E3 proteins, gpl9K, is an integral membrane protein which localizes to the endoplasmic reticulum. It associates with the heavy chain of the class I major histocompatibility complex molecule, causing its retention within the endoplasmic reticulum; the resulting decrease in surface expression of major histocompatibility complex class I may allow Ad-infected cells to escape recognition and lysis by CD8+ cytotoxic T cells (4, 8, 9, 42) . The adenovirus EIA protein induces sensitivity to cytolysis by tumor necrosis factor alpha (TNF-cx) (10, 14) , while three proteins encoded by the Ad E3 region are involved in protection of murine cell lines from lysis by TNF. The 14.7K protein confers protection upon cells spontaneously sensitive to TNF, as well as those sensitized by inhibition of protein synthesis with cycloheximide, by disruption of microfilaments with cytochalasin E or by Ad ElA expression (23, 25, 29) . Stable transfectants of C3HA mouse embryo fibroblasts expressing the 14.7K gene are also resistant to TNF cytolysis in the presence of the above sensitizing agents (28) . Additionally, the E3-encoded 10.4K and 14.5K proteins function together as a plasma membrane-associated complex both to protect cells from lysis by TNF (24) and to promote internalization of the epidermal growth factor receptor (68) . The inhibition of TNF seems important in Ad infection, as yet another protein, the 19K product of the Ad ElB transcription unit, can prevent TNF cytolysis in human (22) and rat (73) cells but not in mouse cells (22) .
TNF-oL is a proinflammatory cytokine produced primarily by activated monocytes and macrophages. This immune mediator is distinguished by the highly pleiotropic nature of its actions: it activates numerous signal transduction pathways, the products of which stimulate an array of transcription factors, which go on to transactivate an assortment of cellular genes (reviewed in references 33, 60, and 71). Mature TNF-oL is an approximately 17-kDa homotrimer (2) , released via proteolysis from a 26-kDa membrane-bound precursor (41) , which binds with high affinity to two distinct and widely distributed receptors of 55 (45, 59) and 75 (62) kDa. In addition to the antitumor activity from which its name derives, TNF is also a potent immunostimulatory agent with a variety of antiviral activities. TNF can be directly cytotoxic to infected cells; for instance, cells infected with vesicular stomatitis virus (1) , herpes simplex virus (HSV) (36) , Newcastle disease virus (46) , and Ad with E3 deletions (23) exhibit increased sensitivity to TNF lysis. The susceptibility to TNF lysis induced by viral infection may be related to the shutoff of host protein synthesis which occurs following some viral infections, in a manner similar to the TNF-sensitizing effects of cycloheximide (77) . response to viral infection is further supported by the finding that TNF expression is induced in lymphoid (RPMI 1788) and myeloid (HL-60) cell lines upon infection with encephalomyocarditis virus, vesicular stomatitis virus, Ad2, or HSV type 2 (76) .
The antiviral activities of TNF in vivo have been less amenable to study because of the high toxicity of this cytokine following systemic administration and its rapid clearance from the circulation, making a local antiviral effect difficult to document (35, 63) . However, it has been shown that a recombinant VV expressing TNF-oL is highly attenuated for murine infection and that this attenuation is not attributable to augmentation of the cell-mediated (cytotoxic T cell, NK cell) or humoral immune responses (58) . In fact, the attenuation is observed in athymic nude or sublethally irradiated mice. Thus, local expression of TNF as directed by the VV vector results in a dramatic, and apparently direct, antiviral activity in vivo in this model.
The mechanism by which the 14.7K protein inhibits TNFmediated cytolysis is unclear. This protein of 128 amino acids in Ad2 has no recognizable structural motifs with defined functions, has not been demonstrated to interact with any known cellular protein (25) , and does not function by decreasing TNF receptor number or affinity (28 protein inhibits cytosolic phospholipase A2, an enzyme which is thought to play a role in TNF-mediated cytolysis. Mutational analysis has shown that deletion of virtually any segment of the 14.7K protein abolishes its ability to protect cells from TNF, while cysteine-to-serine point mutants retain wild-type activity as long as the resulting protein is expressed at wild-type levels (51) . The redundant anti-TNF functions encoded by Ad lead one to speculate that antagonism of TNF's lytic effects is relevant to viral pathogenesis in vivo, but this has not been directly examined. It has been shown that transcription of the TNF-encoding gene is induced upon high-dose Ad infection of mice (a nonreplicating model) (20) and that intranasal infection of cotton rats with an Ad5 deletion mutant lacking the 14.7K, 10.4K, and 14.5K proteins results in a primarily neutrophilic pulmonary inflammatory response, in contrast to the largely monocytic response to wild-type Ad5 (19) . Direct study of the pathogenic effects of the Ad 14.7K protein in convenient murine models is made more difficult by the inability of human Ads to replicate in mice and the absence of the 14.7K protein-encoding gene or a homolog in the mouse Ad (52) .
Our experiments were designed to examine the effect of antagonism of TNF cytolysis by the Ad 14.7K protein on viral pathogenicity in vivo. Because it had already been demonstrated that locally produced TNF-ot has a pronounced attenuating effect on VV virulence, we cloned the Ad2 14.7K protein-encoding gene into a VV vector which also contained the gene for murine TNF-ox to maximize the likelihood of detection of an antagonistic relationship between the two proteins, as reflected by an alteration of VV virulence. Thus, the VV served a dual role: it was the pathogen capable of replication and induction of a lethal disease, as well as the vector for delivery of the agonist (TNF) and its antagonist (the 14.7K protein). In these studies, mice were intranasally infected with the VV constructs and examined for illness, death, pulmonary inflammation, and virus replication in infected tissues.
MATERIALS AND METHODS
Cell lines. The 143B tk human osteosarcoma cell line (obtained from Robert Ricciardi) was maintained in Dulbecco's modified Eagle's medium (DME) supplemented with 10% heat-inactivated fetal bovine serum, 50 U of penicillin per ml, and 50 [Lg of streptomycin per ml. HeLa cells were maintained in suspension culture in Joklik's modified minimal essential medium (Spinner medium) supplemented with 7% bovine calf serum, and penicillin and streptomycin as described above.
Plasmid construction. The BspI2861-DraI digestion product of the Ad2 EcoRI E fragment, containing the 14.7K proteincoding sequence, was cloned into the SmaI site of pUC19. The plasmid thus generated, pUC/14. titration, the portion of the virus stock to be utilized was treated with an equal volume of 0.25-mg/ml trypsin at 37°C for 30 min. The above-described procedure generated parental single recombinant VV containing the 14.7K protein-encoding gene, in either the expressing or the nonexpressing orientation, into which the second insertion, plasmid pFBX-mTNF, was introduced in a similar manner. This insert, which contained the HSV tk gene as a product of early promoter pF, was selected with medium containing 1.5 ,uM methotrexate, 15 p.M thymidine, 50 p.M adenosine, 50 p.M guanosine, and 10 p.M glycine (MTAGG medium) (6, 72) , applied 5 to 6 h postinfection. The resulting viruses, also plaque purified three times and grown as stocks on 143B cells, are designated VV 14.7(+)/TNF and VV 14.7(-)[I)NF. In a similar fashion, we also generated recombinant viruses containing the 14.7K protein-encoding gene, either expressing or nonexpressing, in the HindIII-J region but with only the HSV tk insert in the F region (i.e., no TNF-ox). Plasmid pFBX-mTNF was digested with EcoRI, resulting in removal of the fragment containing the VV p7.5 promoter and the mTNF-cx-encoding gene. The resulting vector was religated and used for insertion of HSV tk into the HindIII-F region of VV. Since numerous insertions into nonessential regions of the VV genome have been shown to have an attenuating effect in vivo (7, 11, 34, 40, 43) 8 ], 100 mM NaCl, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride), and incubated on ice for 20 min. The lysate was spun for 10 min at 14,000 rpm in a microcentrifuge to pellet nuclei and clarify the supernatant, which was boiled in Laemmli sample buffer and run on a sodium dodecyl sulfate-12% polyacrylamide gel. An extract of Ad2-infected HeLa cells, treated with cytosine arabinoside and cycloheximide to enhance production of early proteins after removal of the translational block (17) , was run as a positive control for the presence of the 14.7K protein. The proteins were transferred (Bio-Rad Trans-Blot Cell apparatus) overnight at 14 V and 4°C to a nitrocellulose membrane (Amersham Hybond C Extra) in buffer composed of 20 mM Tris (pH 8), 150 mM glycine, and 20% methanol. The blot was blocked with phosphate-buffered saline (PBS) containing 5% nonfat dried milk (Carnation) and 0.1% Tween 20 (blocking buffer) for 1 h at room temperature. After washing with PBS containing 0.1% Tween 20, the membrane was probed (1 h, room temperature) with a rabbit polyclonal antibody to a TrpE-14.7K fusion protein (a generous gift of William Wold) diluted 1:2,500 in blocking buffer. Following washes with PBS-0.1% Tween 20, the membrane was incubated for l h with a horseradish peroxidase-conjugated donkey anti-rabbit F(ab')2 fragment (Amersham) diluted 1:2,000 in blocking buffer. After the final washes with PBS-0.1% Tween 20, immunoreactivity was detected by treating the blot with a 1:1 mixture of detection reagents (Amersham ECL Western Blotting Detection System) and exposing it to Amersham Hyperfilm-ECL. double-sandwich ELISA technique ( Fig. 2A) while detergent lysates of cell monolayers were assayed for the presence of the 14.7K protein by Western blot (Fig. 2B and C) . Expression of both proteins was detectable by 8 to 12 h postinfection, and the amounts continued to increase to 48 h, consistent with the early-late promoter activity of p7.5. The two recombinants produced similar amounts of TNF ( Fig. 2A) , while cells infected with a control VV lacking the TNF insert secreted no detectable TNF (data not shown). The 14.7K protein was detected only in lysates of cells infected with VV 14.7(+)/TNF, not in lysates of those infected with VV 14.7(-)/TNF; it has the same mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as the 14.7K protein produced by Ad2-infected HeLa cells (Fig. 2C) . No differences were noted regarding the in vitro replicative efficiencies of VV 14.7(+)/ TNF and VV 14.7(-)/TNF in 143B cells, in terms of either virus yield following high-multiplicity infection or plaque morphology. This was not unexpected, since it had been shown that VV expressing mTNF-a (58) or gamma interferon (IFN-^y) (18, 38) replicates to wild-type levels in tissue culture systems although its replication is attenuated in vivo. Ad 14.7K protein increases mortality and morbidity of mice infected with W expressing mTNF-a. Mice were infected to determine the effect of antagonism of TNF cytolysis by the 14.7K protein on VV virulence in vivo. It had been shown that virus-directed TNF expression has a pronounced attenuating effect on VV pathogenesis in normal, euthymic, and immunodeficient (nude or sublethally irradiated) mice (58) . Therefore, we hypothesized that if TNF directly causes the lysis of VV-infected cells and if the Ad 14.7K protein is able to abrogate this cytotoxicity, then the VV recombinant coexpressing TNF and the 14.7K protein should be able to replicate to higher titers and cause greater morbidity and mortality than the virus expressing TNF alone. That is, if the 14.7K protein is able to rescue VV-infected cells from premature lysis by TNF, a lysis occurring prior to the production of a full complement of viral progeny, then virus replication and pathogenicity should be correspondingly enhanced. Figure 3 shows that, the two largest doses of VV administered and 3 to 5 for the smallest dose).
indeed, VV 14.7(+)/TNF was lethal to 3-to 4-week-old BALB/c mice infected intranasally while VV 14.7(-)/TNF at an equivalent input dose (2.5 x 106 PFU) was not lethal. Mice infected with 2.5 x 106 PFU of VV 14.7(+)/TNF, the largest dose administered, began to manifest illness on day 3 to 4 postinfection, as evidenced by decreased activity, ruffling of fur, hunched posture, and rapid, labored respiration. The illness was progressive, with deaths occurring on days 5, 6, and 7. Animals infected with a 10-fold-lower input dose showed similar symptoms in milder form, with a peak of illness on day 5 or 6 postinfection and recovery thereafter. Mice infected with VV 14.7(-)/TNF manifested a consistently milder illness, and there were no deaths. Mice inoculated with 2.5 x 106 PFU of VV 14.7(-)rTNF appeared similar, in terms of clinical illness (hunching, ruffling, etc.), to those receiving a 10-fold lower dilution of VV 14.7(+)/TNF. The cumulative mortality after infection with three different doses of virus (Fig. 4) 10-fold less virus (Fig. 5B) cytokine-mediated antiviral effects. One of these gene products, the Ad 14.7K protein, functions as a general inhibitor of TNF cytolysis in tissue culture systems. However, its influence on viral pathogenesis in an infected host has remained uncharacterized, apart from the finding that deletion of the Ad5 14.7K protein (as well as the other TNF antagonists, the 10.4K and 14.5K proteins) alters the cellular nature of the inflammatory response from largely monocytic to primarily neutrophilic in cotton rat lungs.
We have shown that expression of the Ad2 14.7K protein by a recombinant VV which also expresses mTNF-cx results in significant reversal of the TNF-mediated viral attenuation initially described by Sambhi et al. (58) (16, 50) , IFN-y (18, 38, 58) , and TNF-ao (58) are attenuated for infection of nude mice, and the interleukin-2-induced reduction in virulence depends, in part, on NK cells and production of IFN-y. VV replicates to higher titers and is more lethal in mice that are homozygous for disruption of the IFN-,y receptor gene (IFN--yR0/0) (31) . In addition, pretreatment of mice with IFN-ao/1 inhibits viral gene expression, determined by assaying the activity of a luciferase reporter gene inserted into the VV genome (54) .
Study of poxvirus genes and their expression has also supported the importance of cytokine antagonists in evasion of the host immune response (3, 53, 64, 70) . For (23) ; is antiviral in vitro, especially in synergy with IFN--y (76); and augments the IFN-y-induced block to Ad assembly (47) . Three Ad E3 genes (the 14.7K, 10 .4K, and 14.5K protein-encoding genes) are involved in antagonism of TNF cytolysis, and the E3 promoter from which these genes are expressed is activated by TNF (39 
